Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo Pureco Pratama Tbk. (IPPE) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Indo Pureco Pratama Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo Pureco Pratama Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo Pureco Pratama Tbk. trades at Rp14 (market cap 64.4B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 10.7× Indo Pureco Pratama Tbk.'s market cap. Which is the better fit depends on your goals.

IPPELABS
Market Cap
64.4B691.25B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details

About Indo Pureco Pratama Tbk.

PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.

Read more on IPPE

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS